Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Revenue

Indo-Bangla Pharmaceuticals had revenue of 42.81M BDT in the quarter ending March 31, 2026, with 95.58% growth. This brings the company's total for the last twelve months to 242.10M, up 165.76% year-over-year. In the fiscal year ending June 30, 2025, Indo-Bangla Pharmaceuticals had annual revenue of 184.18M with 4.27% growth. That makes Indo-Bangla Pharmaceuticals the 42,460th largest company in the world by revenue and 270th in Bangladesh.

• Revenue (ttm): 242.10M
• Revenue Growth: +165.76%
• P/S Ratio: 6.77
• Revenue / Employee: n/a
• Employees: 127
• Market Cap: 1.64B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	184.18M	7.54M	4.27%
Jun 30, 2024	176.64M	-197.84M	-52.83%
Jun 30, 2023	374.48M	-110.20M	-22.74%
Jul 1, 2022	484.68M	-297.56M	-38.04%
Jul 1, 2021	782.24M	-83.86M	-9.68%

Data Source: S&P Global Market Intelligence Last updated: Jun 1, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error